Current dogma suggests that fluid overload—when associated with acute kidney injury (AKI)—is an independent risk factor for death. Although the volume status of the patient is important, there are ...

All patients undergoing CRRT while on ECLS between 2005 and 2010 at Seattle Children's Hospital (n = 42) were identified by a retrospective review of a prospectively maintained institutional database.

CRRT allows for slow and continuous removal of fluid and toxins, which can be better tolerated than other conventional treatments in patients who are hemodynamically unstable. Replacement fluids are ...

Please provide your email address to receive an email when new articles are posted on . Mortality at 28 days was lower in patients who received continuous renal replacement therapy within 12 hours of ...

The work group aimed to make recommendations to clarify the processes for prescribing and preparing CRRT solutions based on the medication error data collected by the ...

MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NUWE) (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the ...

Continuous renal replacement therapy (CRRT) is the preferred treatment for acute kidney injury (AKI) in intensive care units (ICUs) throughout much of the developed world. Despite its widespread use, ...

The FDA has approved Phoxillum replacement solution for use during continuous renal replacement therapy (CRRT). Phoxillum can replace plasma volume removed by ultrafiltration and correct electrolyte ...

Only authorized citrate-based replacement solution available in the U.S. for use in continuous renal replacement therapy (CRRT) during COVID-19 pandemic Supports need for regional citrate ...